Fred Ashbury, BA (Hons), MA, PhD is Chief Scientific Officer at Viecure, and is one of the company’s founders. He is responsible for identifying, consolidating and codifying the evidence base of leading cancer agencies and organizations in standard of care and precision oncology so the VieCure artificial intelligence platform, including its smart EMR, can provide real-time considerations to oncologists at point-of-care to optimize patient success.
During his career, Fred has held senior positions in the National Cancer Institute of Canada, Cancer Care Ontario, the Alberta Cancer Board, OpTx Corporation, BridgeSite Clinical Research, PWC and Intelligent Improvement Consultants. He is a member of the American Society of Clinical Oncology, the Multinational Association of Supportive Care in Cancer (ex officio board member), the American College of Epidemiology, and the Canadian Association of Psychosocial Oncology, and is the Editor-in-Chief, Supportive Care in Cancer.
Fred received his doctorate from York University, is an Adjunct Professor at the Dalla Lana School of Public Health, University of Toronto, Canada and the Department of Oncology, University of Calgary, and has published more than 80 peer-reviewed articles and major reports.